Tim Schlidt is Funding a New Paradigm in Wellbeing

On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo.

Palo Santo is a leading therapeutics investment fund dedicated to increasing the global supply of clinically effective and accessible healthcare solutions.

Tim is a Co-Founder and Partner of the fund, sits on the Board of many psychedelics companies, and recently closed a $50 million fund.

Tune in to learn more about Palo Santo's investment thesis, portfolio, and goals for the future of psychedelic-assisted therapies and beyond.